Search Medical Condition
Please enter condition
Please choose location from dropdown

Yeast Infections Clinical Trials

A listing of Yeast Infections medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

DO YOU HAVE VAGINAL SYMPTOMS? We are currently testing new investigational medications for vaginal infections. We are currently seeking women to participate in a research study. IF YOU HAVE ANY OF THE FOLLOWING SYMPTOMS, YOU MAY QUALIFY: Itching Burning Irritation Odor Discharge To be eligible, you must meet certain other ...

Phase

"Vaginitis" (Bacterial Infection) is a medical term used to describe various conditions that cause infection or inflammation of the vagina. Vulvovaginitis refers to inflammation of both the vagina and vulva (the external female genitals). These conditions can result from a vaginal infection caused by organisms such as bacteria, yeast, or ...

Phase N/A

The DOVE study is currently underway to test the safety and effectiveness of an investigational medication for Vulvovaginal Candidiasis, also known as a yeast infection. 

Phase N/A

Studies of Disorders With Increased Susceptibility to Fungal Infections

This study is designed for the evaluation, diagnosis, and long-term follow up of selected patients with primary immune deficiencies and other conditions associated with fungal, and more specifically with Candida spp. infections. The primary immune deficiencies to be studied include, but are not limited to, autoimmune polyendocrinopathy candidiasis ectodermal dystrophy ...

Phase N/A

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

This protocol is a prospective, interventional, randomized, double-blind, placebo controlled longitudinal study designed to investigate the microbiomic and immunologic perturbations that lead to vulvovaginal candidiasis (VVC) in women who receive antibiotics. VVC is the most common fungal infection affecting women. Although asymptomatic vaginal Candida colonization occurs in ~10-20% of healthy ...

Phase N/A

Ambisome Preemptive Treatment of Multiple Candida Colonization in Sepsis Patients

To assess the safety of Ambisome 10 mg/kg/week in patients as a preemptive treatment in intensive care patients with a sepsis and rising candida colonisation. Preemptive treatment (i.e., prophylactic treatment with two high doses of Ambisome® administered with an interval of one week, in patiens with a high risk of ...

Phase